| Literature DB >> 35334533 |
Ahmet Parlak1, Marvin Darkwah Oppong1, Ramazan Jabbarli1, Oliver Gembruch1, Philipp Dammann1, Karsten Wrede1, Laurèl Rauschenbach1, Ulrich Sure1, Neriman Özkan1.
Abstract
Background andEntities:
Keywords: gross total resection; peripheral nerve sheath tumours; recurrence rate; spinal schwannoma; subtotal resection
Mesh:
Year: 2022 PMID: 35334533 PMCID: PMC8950654 DOI: 10.3390/medicina58030357
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Figure 1The four schwannoma localisations as described by Sun et al.: (a): exclusively intradural localisation (I), (b): intradural localisation with extradural extension to the nerve root foramina, but restricted to the spinal canal (II), (c): intradural tumour extending to the extraforaminal region (III), (d): localisation completely outside of the foramina (IV).
Patient and tumour characteristics.
|
| % | ||
|---|---|---|---|
| Gender | Female | 18 | 36 |
| Age (years) a | 46 (±14) | ||
| Clinical presentation | Symptoms related to tumor: | 46 | 92 |
| Radiculopathy b | 44 | 88 | |
| Spinal deficit | 11 | 22 | |
| Unrelated symptom(s) leading to diagnosis | 4 | 8 | |
| Time between first symptoms and diagnosis (months) | 16 (35) | ||
| Tumour characteristics (MR imaging) | |||
| Tumour localisation | Cervical | 15 | 30 |
| Thoracal | 6 | 12 | |
| Lumbosacral | 29 | 58 | |
| Central | 9 | 18 | |
| Lateral: | 41 | 82 | |
| Right | 21 | 42 | |
| Left | 20 | 40 | |
| Volume of tumour (cm3) | Mean volume a | 9.7 (18.8) | |
| Size A (0–2) | 22 | 44 | |
| Size B (2–6) | 12 | 24 | |
| Size C (>6) | 16 | 32 | |
| Localisation type | I | 17 | 34 |
| II | 11 | 22 | |
| III | 18 | 36 | |
| IV | 4 | 8 | |
| Presence of myelopathy | yes | 6 | 12 |
a Mean (SD); b Radiculopathy was defined as paresis, hypaesthesia, paraesthesia as well as dysaesthesia.
Univariate analysis.
|
| |||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| Tumour size | |||||
|
|
|
|
|
|
|
| B | 11 | 1 | 0.248 | 4.48 | 0.52–39.01 |
|
|
|
|
|
|
|
| Localisation type | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IV | 3 | 1 | >0.99 | 0.94 | 0.09–10.01 |
|
| |||||
|
|
| ||||
| Tumour size | |||||
| A | 16 | 6 | 0.919 | 1.07 | 0.31––3.71 |
| B | 9 | 3 | >0.99 | 1.22 | 0.28–5.38 |
| C | 11 | 5 | 0.746 | 0.79 | 0.22–2.92 |
| Localisation type | |||||
|
|
|
|
|
|
|
| II | 9 | 2 | 0.705 | 2.00 | 0.37–10.69 |
| III | 10 | 8 | 0.052 | 0.29 | 0.08–1.04 |
| IV | 1 | 3 | 0.061 | 0.11 | 0.01–1.11 |
| Myelopathy | 5 | 1 | 0.663 | 2.01 | 0.22–19.75 |
|
|
| ||||
| IONM | 2 | 20 | 0.683 | 0.60 | 0.10–3.62 |
| IONM alteration | 0 | 3 | >0.99 | 1.00 | 0.04–25.69 |
| Resection intralesional | 4 | 29 | >0.99 | 1.03 | 0.17–6.31 |
| Myelopathy | 0 | 6 | >0.99 | 0.52 | 0.02–9.10 |
| GTR | 4 | 34 | 0.621 | 0.588 | 0.09–3.67 |
| Tumour size | |||||
| A | 2 | 20 | 0.683 | 0.60 | 0.10–3.62 |
| B | 2 | 10 | 0.621 | 1.70 | 0.27–10.68 |
| C | 2 | 14 | >0.99 | 1.07 | 0.18–6.56 |
| Tumour localisation | |||||
| I | 2 | 9 | 0.601 | 1.94 | 0.31–12.35 |
| II | 3 | 15 | 0.654 | 1.93 | 0.35–10.77 |
| III | 0 | 4 | >0.99 | 0.69 | 0.03–14.43 |
| IV | 2 | 9 | 0.601 | 1.94 | 0.31–12.35 |
Figure 2MR Imaging (T2-weighted on the left, T1 with gadolinium on the right) showing a large intradural, contrast-enhancing lesion (marked with asterisk) compressing the cervical spinal cord (a,b). Postoperative MR Imaging showing no signs of tumour recurrence (c,d).
Figure 3Intraoperative view after showing a large intradural schwannoma (marked with asterisk). The schwannoma is mobilised cranially, the compressed spinal cord is visible caudally.